CLOVER HEALTH INVESTMENTS CORP. - CLASS A COMMON

PCP Use of Clover Assistant Correlated with Increased Medication Fills for Patients who Were Previously Non-Adherent

08 Jan 2024 17:00:00 By Nasdaq GlobeNewswire

Clover Health Announces Departure of Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for 2023

21 Dec 2023 08:00:00 By Nasdaq GlobeNewswire

Clover Health to Present at 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024

18 Dec 2023 16:05:00 By Nasdaq GlobeNewswire

Clover Health Exits ACO REACH to Accelerate Path to Profitability

01 Dec 2023 08:15:00 By Nasdaq GlobeNewswire

Clover Health Reports Third Quarter 2023 Results; Highlights Continued Improvement in Financial Performance and Improved 2023 Guidance

06 Nov 2023 16:05:01 By Nasdaq GlobeNewswire

Clover Health Promotes Karen Soares to General Counsel

01 Nov 2023 09:00:00 By Nasdaq GlobeNewswire

Clover Health to Report Third Quarter 2023 Financial Results on November 6, 2023

17 Oct 2023 16:30:00 By Nasdaq GlobeNewswire

Clinician Use of Clover Assistant is Associated with Earlier Identification and Management of Diabetes

12 Oct 2023 08:30:00 By Nasdaq GlobeNewswire

Clover Health to Present at Maxim Group Emerging Growth in A.I. Virtual Conference on September 26, 2023

22 Sep 2023 09:00:00 By Nasdaq GlobeNewswire

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

20 Sep 2023 16:30:00 By Nasdaq GlobeNewswire

Clover Health Reports Strong Second Quarter 2023 Results; Highlights Improved Financial Performance and Guidance Ranges

08 Aug 2023 16:05:01 By Nasdaq GlobeNewswire

Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement

03 Aug 2023 16:15:00 By Nasdaq GlobeNewswire

Clover Health to Present at Canaccord Genuity 43rd Annual Growth Conference and 2023 Wells Fargo Healthcare Conference

02 Aug 2023 16:05:00 By Nasdaq GlobeNewswire

Clinician Use of Clover Assistant is Associated with Significant Improvement in the Early Identification and Management of Chronic Kidney Disease

01 Aug 2023 16:20:00 By Nasdaq GlobeNewswire

Clover Health to Report Second Quarter 2023 Financial Results on August 8, 2023

11 Jul 2023 16:05:00 By Nasdaq GlobeNewswire

Clover Health Announces Agreement to Settle Derivative Litigation, Resolving All Remaining Civil Litigation Relating to its de-SPAC Transaction

22 Jun 2023 16:05:00 By Nasdaq GlobeNewswire

Clover Health Reports First Quarter 2023 Financial Results

09 May 2023 16:34:50 By Nasdaq GlobeNewswire

Clover Health to Present at Bank of America 2023 Healthcare Conference on May 11, 2023

04 May 2023 16:05:01 By Nasdaq GlobeNewswire

Clover Health Announces Agreement to Settle Securities Class Action Litigation

24 Apr 2023 09:00:00 By Nasdaq GlobeNewswire

Clover Health Announces Business Transformation Initiatives to Accelerate Path to Profitability

17 Apr 2023 09:00:01 By Nasdaq GlobeNewswire